CVE-2026-21082: Relative path traversal in Samsung Health prior to version 7.0.0 allows local attackers to access sensitive in
CVE-2026-21082 is a medium-severity flaw (CVSS 5.5) affecting health. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
Relative path traversal in Samsung Health prior to version 7.0.0 allows local attackers to access sensitive information.
Why this priority
- No elevated risk signals yet
A fixed release or distro patch exists.
Risk facts
| CVSS score | 5.5 (Medium) |
| Attack vector | Local |
| Attack complexity | Low |
| Privileges needed | Low |
| User interaction | None |
| EPSS exploit chance | 0.2% (top 95%) |
| CISA exploited list | No |
| Weakness | CWE-23 |
| Published | 2026-08-10 |
| Last modified | 2026-10-23 |
Last updated 2026-10-23 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2026-21082?
health: upgrade to 7.0.0. Exact commands for each OS are on this page.
Is CVE-2026-21082 being exploited?
CVE-2026-21082 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2026-21082 affect?
CVE-2026-21082 affects health. Severity is medium (CVSS 5.5). Relative path traversal in Samsung Health prior to version 7.0.0 allows local attackers to access sensitive information.
How urgent is CVE-2026-21082?
Priority 21/100. No elevated risk signals yet.
Software pages
Related CVEs
- CVE-2026-21076 MEDIUM 5.5 UPGRADE Incorrect authorization in Samsung Health prior to version 7.0.0 allows local attackers to access sensitive in
- CVE-2026-21077 MEDIUM 5.5 UPGRADE Incorrect authorization in Samsung Health prior to version 7.0.0 allows local attackers to access sensitive in